Screener
Medtronic MDT Diabetes — Currency translation and other
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
FAQ
- What is Medtronic's diabetes — currency translation and other?
- Medtronic (MDT) reported diabetes — currency translation and other of $0 in Q4 2025.
- What is the long-term trend for Medtronic's diabetes — currency translation and other?
- Over 3 years (2022 to 2025), Medtronic's diabetes — currency translation and other has grown at a 0.0% compound annual growth rate (CAGR), from -$1M to $1M.
- What does diabetes — currency translation and other mean?
- This captures the impact of foreign exchange rate fluctuations on the diabetes segment's financial results, along with minor non-recurring items. Because the company has significant international operations, currency volatility can distort reported revenue and profit growth. This metric helps investors isolate the operational performance from the effects of global currency markets.
Ask your AI about Medtronic's diabetes — currency translation and other.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude